-
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Post on 2/1/21
-
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Post on 2/1/21
-
Scopus BioPharma Closes $9M Follow-On Public Offering
Post on 1/30/21
-
Bioasis Announces $200,000 Non-Brokered Private Placement
Post on 1/30/21
-
VYNE Therapeutics Closes of $50 Million Registered Direct Offering of Common Stock
Post on 1/29/21
-
Better Buy: Pfizer vs. BioNTech
Post on 1/29/21
-
Seelos Therapeutics Closes of Public Offering of Common Stock
Post on 1/28/21
-
Ortho Clinical Diagnostics Prices IPO
Post on 1/27/21
-
Citius Pharmaceuticals Closes of $20.0 Million Private Placement
Post on 1/27/21
-
DarioHealth Acquires Upright Technologies
Post on 1/27/21
-
Cedar Partnership with Yale New Haven Health
Post on 1/27/21
-
Thermo Fisher Scientific Launches First T-cell Medium Specifically
Post on 1/27/21
-
Comcast Ties Up With WWE in Peacock Streaming Deal
Post on 1/27/21
-
Why Pfizer Will Make More Money Than Originally Expected in 2021
Post on 1/27/21
-
Should You Buy Johnson & Johnson Stock Before Its Big Coronavirus Vaccine News?
Post on 1/27/21
-
Is Pfizer A Great Dividend Stock?
Post on 1/27/21
-
Here's Why Investors Cheered Johnson & Johnson's Q4 Results
Post on 1/27/21
-
Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes
Post on 1/27/21
-
Scopus BioPharma Announces Pricing of $9 Million Follow-On Public Offering
Post on 1/26/21
-
Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results
Post on 1/26/21
-
Seelos Therapeutics Prices of $31.25 Million Public Offering of Common Stock
Post on 1/26/21
-
VYNE Therapeutics Sale of $50 Million Registered Direct Offering of Common Stock
Post on 1/26/21
-
Pacira BioSciences Equity Invest in GeneQuine Biotherapeutics
Post on 1/26/21
-
Grant Avenue Capital Acquires Valeo Home Health and Hospice
Post on 1/26/21
-
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
Post on 1/26/21
New York
